Product Due Diligence

Product due diligence is the product side of recommendation quality. A representative should not recommend a security, fund, note, or strategy merely because the sales material looks strong or because the product sits on the firm’s shelf. The product should be understood well enough that its structure, costs, liquidity, and risks can be explained and matched to client needs.

For CPH purposes, the strongest answer usually connects three ideas:

1. what the product actually is
2. what risks, costs, and constraints attach to it
3. whether the dealer and representative have done enough work to recommend it responsibly

Product Due Diligence Supports KYP

Current Canadian conduct expectations require a genuine know-your-product discipline. At a high level:

• the firm is responsible for broader product review, approval, and shelf governance
• the representative is responsible for understanding approved products well enough to explain and recommend them properly

Students should avoid the weak answer that all due diligence is the compliance department’s responsibility. A representative who cannot explain how the product works is not in a strong position to recommend it.

Start with the Issuer and Product Structure

Due diligence begins with understanding who is behind the product and how the product is built.

Important questions include:

• Who is the issuer or manufacturer?
• What is the product designed to do?
• What underlying assets, strategies, or promises drive the outcome?
• Is the return profile simple, leveraged, conditional, or path-dependent?
• Are there maturity, lock-up, redemption, or reset features that matter?

This matters because two products that appear similar on a sales sheet may behave very differently once their internal structure is understood.

Costs Are Part of Product Fit

Cost review is not a secondary issue. It is part of the product analysis itself. A product may look attractive in theme but still be weak for the client if costs absorb too much of the expected benefit.

Relevant cost questions often include:

• What does the client pay up front?
• What ongoing fees or embedded costs apply?
• Are there performance fees, trading spreads, or surrender charges?
• Do the costs make the product meaningfully less attractive than simpler alternatives?

The exam often rewards the student who notices that a product’s cost structure weakens the recommendation even if the product category itself appears suitable.

Liquidity and Exit Terms Need Specific Review

Representatives should understand whether the client can exit the product:

• daily or only periodically
• at net asset value or through a secondary market
• without material penalties or discounts
• without operational delay in stressed conditions

Liquidity is especially important when the client may need access to cash on short notice. A product with long lock-up terms or limited secondary liquidity can be unsuitable even where its return story is appealing.

Risk Review Should Be Multi-Dimensional

A strong product review should consider more than ordinary market volatility. Depending on the product, the due-diligence analysis may need to address:

• market risk
• credit or issuer risk
• liquidity risk
• leverage risk
• concentration risk
• counterparty or operational risk
• structural or payoff complexity

For CPH purposes, the exam often tests whether the student recognized the risk that actually matters most. A product with an attractive coupon or yield may still be weak if the investor is effectively taking equity downside, concentrated issuer exposure, or difficult-to-exit risk that was not explained clearly.

    flowchart TD
	    A[Product proposed for use] --> B[Review issuer and structure]
	    B --> C[Review costs and liquidity]
	    C --> D[Review major risks and scenarios]
	    D --> E[Firm approval and shelf decision]
	    E --> F[Representative explains and applies to client]
	    F --> G[Ongoing monitoring]

The process matters because product due diligence is not finished when the product first appears on a list. It should continue through recommendation and later monitoring.

Shelf Approval Does Not End the Analysis

If a product has been approved by the firm, that solves one problem but not every problem. The representative still needs to consider:

• whether the product fits this specific client
• whether a simpler or lower-cost option on the shelf would serve the client better
• whether current market or issuer conditions have changed the product’s risk profile

A shelf-approved product can still be the wrong choice for a particular client or a weak choice when compared with other reasonably available options.

Ongoing Monitoring Matters After Approval

Product due diligence is not a set-and-forget exercise. The representative and the firm should remain alert to changes such as:

• issuer credit deterioration
• material strategy changes
• fee or redemption changes
• market conditions that alter the product’s behaviour
• regulatory or disclosure developments affecting use of the product

This is especially important for products with complex structures, alternative strategies, or meaningful liquidity constraints.

Documentation Should Show the Analysis

Good due diligence produces a record showing:

• what information was reviewed
• what risks and costs were identified
• whether shelf approval existed
• what key cautions or limits apply
• how the product was later explained and applied in a client recommendation

Without that record, a representative may struggle to show that the recommendation reflected product knowledge rather than sales enthusiasm.

Common Pitfalls

• Relying too heavily on issuer marketing materials.
• Treating shelf approval as proof that the product fits every client.
• Ignoring cost impact because the product category sounds attractive.
• Underestimating liquidity or structural complexity.
• Failing to revisit the product when issuer or market conditions change.

Key Takeaways

• Product due diligence is a core part of know-your-product discipline.
• Representatives should understand issuer quality, structure, cost, liquidity, and risk before recommending a product.
• Shelf approval helps, but it does not remove the need for client-specific judgment.
• Ongoing monitoring matters when conditions or product features change.
• Documentation should show what the product review actually covered.

Sample Exam Question

A representative wants to recommend a structured note with a high advertised coupon. The note is on the firm’s approved shelf, but the representative has not reviewed the downside payoff mechanics, the issuer’s recent credit deterioration, or the limited liquidity before maturity. The client may need access to funds within two years.

What is the strongest assessment?

• A. The recommendation is acceptable because shelf approval replaces further product analysis by the representative.
• B. The recommendation is weak because important structure, issuer, and liquidity issues were not analyzed before matching the product to the client.
• C. The recommendation is acceptable because a high coupon usually compensates for any product risk.
• D. The recommendation is acceptable if the client signs a general risk disclosure.

Answer: B. A representative should understand the product well enough to analyze its real risk, liquidity, and issuer exposure before recommending it, even when the product is already approved by the firm.